Get started
Author

Pauline A. Zellenrath

Observed names: P Zellenrath, P. Zellenrath, Pauline A Zellenrath, Pauline Zellenrath
ORCID: 0009-0003-4902-5663
Observed ORCID: 0009-0003-4902-5663
OpenAlex ID: A5006745990
Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
2023 · Bas L. A. M. Weusten, Raf Bisschops, et al. · Endoscopy · 213
PDF
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus
2024 · Sarah E. Laun, Lisa Kann, et al. · The American Journal of Gastroenterology · 17
Discovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma
2025 · Andrew Kalra, Ke Ma, et al. · The American Journal of Gastroenterology · 16
Self-expandable duodenal metal stent placement for the palliation of gastric outlet obstruction over the past 20 years
2022 · Agnes N. Reijm, Pauline A. Zellenrath, et al. · Endoscopy · 12
PDF
Neoplastic Progression Risk in Females With Barrett’s Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data
2024 · Pauline A. Zellenrath, Laurelle van Tilburg, et al. · Clinical Gastroenterology and Hepatology · 9
Sex Differences in Neoplastic Progression in Barrett’s Esophagus: A Multicenter Prospective Cohort Study
2022 · Carlijn A. M. Roumans, Pauline A. Zellenrath, et al. · Cancers · 5
PDF
Lessons learned: the importance of timely recognition of verrucous squamous cell carcinoma in the esophagus
2026 · Nanda Provoost, Pauline A Zellenrath, et al. · Diseases of the Esophagus · 2
Aberrant p53 expression, a stronger risk factor for neoplastic progression in Barrett’s esophagus than confirmed low grade dysplasia: a large multicenter prospective cohort study
2026 · Pauline A. Zellenrath, Nanda Provoost, et al. · Endoscopy · 1
PDF
Today’s Mistakes and Tomorrow’s Wisdom… In Barrett’s Surveillance
2022 · Pauline A. Zellenrath, Carlijn A.M. Roumans, et al. · Visceral Medicine · 1
PDF
High rate of neoplasia diagnosis at endoscopic reassessment and incidence of progression in patients with ultra-long Barrett esophagus referred to expert centers
2026 · Eva P.D. Verheij, Maartje T.P.M. Houben, et al. · Endoscopy
Sex does not reliably predict neoplastic progression in Barrett’s esophagus patients: a prospective multi-center cohort study
2026 · Pauline A. Zellenrath, Man-Wai Chan, et al. · npj Women s Health
PDF
Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett’s Esophagus
2025 · N Provoost, P Zellenrath, et al. · Endoscopy
Positive family history of esophageal adenocarcinoma or Barrett’s esophagus as risk factor for neoplastic progression in patients with Barrett’s esophagus
2025 · N Provoost, A E De Groen, et al. · Endoscopy
Efficacy of a higher-flexibility duodenal stent for palliation of gastric outlet obstruction
2025 · Noa Eveline Adriana Kapteijn, Pauline A. Zellenrath, et al. · Endoscopy International Open
PDF
Additional Value of Expert Care for Patients With Ultra-long Barrett's Esophagus in the Netherlands: Results of the Nationwide Barrett Expert Center Registry
2024 · Eva Verheij, Maartje Houben, et al. · Gastrointestinal Endoscopy
Additional value of expert care for patients with ultra-long Barrett’s Esophagus in the Netherlands: results of the nationwide Barrett Expert Center Registry
2024 · E.P. D. Verheij, M. Houben, et al. · Endoscopy
221 Aberrant P53 Expression Is the Strongest Predictor for Neoplastic Progression in Patients With Barrett's Esophagus.
2023 · Pauline Zellenrath, Judith Honing, et al. · Gastroenterology
Aberrant p53 expression is the strongest predictor for neoplastic progression in patients with Barrett’s esophagus
2023 · P. Zellenrath, J. Honing, et al. · Endoscopy
Self-expandable Duodenal Metal Stent Placement for Palliation of Gastric Outlet Obstruction Over the Past 20 Years in a Tertiary Hospital in the Netherlands
2022 · A. Reijm, P. Zellenrath, et al. · Endoscopy
Works count: 19
Citation count: 276
H-index: 5
I10-index: 4
Year
Topic
Type